{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "exchange": "ASX", "shortName": "BIOTRON FPO", "longName": "Biotron Limited", "messageBoardId": "finmb_7658306", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.028, "marketState": "PRE", "fiftyTwoWeekHighChangePercent": -0.7395349, "fiftyTwoWeekLow": 0.0255, "fiftyTwoWeekHigh": 0.1075, "earningsTimestamp": 1682557213, "earningsTimestampStart": 1682557213, "earningsTimestampEnd": 1682557213, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.0, "sharesOutstanding": 901945024, "bookValue": 0.007, "fiftyDayAverage": 0.02777, "fiftyDayAverageChange": 0.00023000129, "fiftyDayAverageChangePercent": 0.008282365, "twoHundredDayAverage": 0.037264854, "twoHundredDayAverageChange": -0.009264853, "twoHundredDayAverageChangePercent": -0.24862175, "marketCap": 25254462, "priceToBook": 4.0, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683770388, "regularMarketDayHigh": 0.028, "regularMarketDayRange": "0.028 - 0.028", "regularMarketDayLow": 0.028, "regularMarketVolume": 1053099, "regularMarketPreviousClose": 0.028, "bid": 0.028, "ask": 0.028, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.028, "averageDailyVolume3Month": 771934, "averageDailyVolume10Day": 1044861, "fiftyTwoWeekLowChange": 0.0025000013, "fiftyTwoWeekLowChangePercent": 0.09803927, "fiftyTwoWeekRange": "0.0255 - 0.1075", "fiftyTwoWeekHighChange": -0.079500005, "firstTradeDateMilliseconds": 980290800000, "symbol": "BIT.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "66 Hunter Street", "address2": "Level 2", "city": "Sydney", "state": "NSW", "zip": "2000", "country": "Australia", "phone": "61 2 9300 3344", "fax": "61 2 9221 6333", "website": "https://www.biotron.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Michelle  Miller BSc., GCertAppFin, MSc., Ph.D.", "title": "MD & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 369854, "fmt": "369.85k", "longFmt": "369,854"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter James Nightingale B.Econ, CA", "age": 65, "title": "Company Sec.", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 84000, "fmt": "84k", "longFmt": "84,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Stephen L. Becker M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}